Budipine in the Treatment of Extrapyramidal Disorders Not Related to Parkinson’s Disease

Author(s):  
D. Müller
2021 ◽  
Vol 74 (10) ◽  
pp. 2494-2502
Author(s):  
Nataliya G. Pakhomova ◽  
Ivan М. Okhrimenko ◽  
Svitlana V. Kul’bida ◽  
Tamara A. Yanovska ◽  
Halyna M. Stanetska

The aim is to determine the neuropsychological peculiarities of cognitive and communicative activities in adults with the extrapyramidal system disorders. Materials and methods: The research was conducted during 2018-2021, during which a retrospective analysis of medical treatment records of the patients with extrapyramidal disorders of various etiologies was performed. The research involved 137 adult patients with extrapyramidal disorders: 93 persons with Parkinson’s disease, 36 people with manganese encephalopathy, 5 persons with progressive supranuclear palsy and 3 people with Wilson-Konovalov disease. Results: A significant difference between the indicators of preservation of cognitive and communicative activities and the communicative and semantic component in the group of patients with Parkinson’s disease without speech disorders and Parkinson’s disease and between the groups of patients with Parkinson’s disease without speech disorders and progressive supranuclear palsy indicates the need for experimental correctional and rehabilitation work to restore cognitive and communicative activities of the patients with extrapyramidal disorders. Conclusions: The most preserved communicative and speech function was found in the patients who had initial and mild stages of the disease, in particular in the patients with Parkinson’s disease without speech disorders. It should be emphasized that the diagnosis of cognitive and communicative activities and the communicative and semantic component in adults with extrapyramidal disorders is a necessary prerequisite for the organization of the process of comprehensive rehabilitation treatment.


Author(s):  
Nuriye Yıldırım Gökay ◽  
Bülent Gündüz ◽  
Fatih Söke ◽  
Recep Karamert

Purpose The effects of neurological diseases on the auditory system have been a notable issue for investigators because the auditory pathway is closely associated with neural systems. The purposes of this study are to evaluate the efferent auditory system function and hearing quality in Parkinson's disease (PD) and to compare the findings with age-matched individuals without PD to present a perspective on aging. Method The study included 35 individuals with PD (mean age of 48.50 ± 8.00 years) and 35 normal-hearing peers (mean age of 49 ± 10 years). The following tests were administered for all participants: the first section of the Speech, Spatial and Qualities of Hearing Scale; pure-tone audiometry, speech audiometry, tympanometry, and acoustic reflexes; and distortion product otoacoustic emissions (DPOAEs) and contralateral suppression of DPOAEs. SPSS Version 25 was used for statistical analyses, and values of p < .05 were considered statistically significant. Results There were no statistically significant differences in the pure-tone audiometry thresholds and DPOAE responses between the individuals with PD and their normal-hearing peers ( p = .732). However, statistically significant differences were found between the groups in suppression levels of DPOAEs and hearing quality ( p < .05). In addition, a statistically significant and positive correlation was found between the amount of suppression at some frequencies and the Speech, Spatial and Qualities of Hearing Scale scores. Conclusions This study indicates that medial olivocochlear efferent system function and the hearing quality of individuals with PD were affected adversely due to the results of PD pathophysiology on the hearing system. For optimal intervention and follow-up, tasks related to hearing quality in daily life can also be added to therapies for PD.


Sign in / Sign up

Export Citation Format

Share Document